PRE
Prenetics Global Ltd
NASDAQ: PRE · HEALTHCARE · DIAGNOSTICS & RESEARCH
$16.71
-4.02% today
Updated 2026-04-30
Market cap
$310.15M
P/E ratio
—
P/S ratio
3.36x
EPS (TTM)
$-3.79
Dividend yield
—
52W range
$5 – $24
Volume
0.2M
Prenetics Global Ltd (PRE) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.87B | $4.17B | $4.21B | $4.19B | $4.15B | $4.00B | $5.33B | $5.90B | $5.40B | $5.56B | $5.59B | $6.48B | $5.48B | $9.23M | $65.18M | $12.53M | $13.16M | $21.74M | $30.62M | $92.39M |
| Revenue growth (YoY) | — | +7.7% | +0.8% | -0.4% | -0.9% | -3.6% | +33.3% | +10.7% | -8.6% | +3.1% | +0.5% | +15.9% | -15.4% | -99.8% | +605.9% | -80.8% | +5.0% | +65.2% | +40.8% | +201.7% |
| Cost of revenue | $3.37B | $3.65B | $4.21B | $3.27B | $3.26B | $3.87B | $3.56B | $4.70B | $5.74B | $4.15B | $4.68B | $5.12B | $4.76B | $6.52M | $38.83M | $8.93M | $9.55M | $12.91M | $15.22M | $43.45M |
| Gross profit | $498.19M | $524.07M | — | $917.26M | $952.10M | $106.85M | $1.77B | $1.16B | — | $1.41B | $860.40M | $1.36B | $668.70M | $2.72M | $26.34M | $3.60M | $3.62M | $8.83M | $15.40M | $48.94M |
| Gross margin | 12.9% | 12.6% | 0.0% | 21.9% | 22.9% | 2.7% | 33.2% | 19.6% | 0.0% | 25.3% | 15.4% | 21.0% | 12.2% | 29.4% | 40.4% | 28.7% | 27.5% | 40.6% | 50.3% | 53.0% |
| R&D | — | — | — | — | — | — | — | — | — | — | — | — | — | $2.99M | $2.78M | $6.39M | $5.99M | $11.66M | $10.92M | $5.13M |
| SG&A | — | — | — | — | — | — | — | — | — | — | — | — | — | $13.19M | $16.62M | $47.93M | $59.34M | $41.44M | $46.73M | — |
| Operating income | $498.19M | $524.07M | — | $917.26M | $952.10M | $106.85M | $1.73B | $1.09B | — | $1.38B | $833.23M | $1.33B | $642.11M | $-20.80M | $-995126.00 | $-56.66M | $-66.02M | $-51.91M | $-48.14M | $-37.38M |
| Operating margin | 12.9% | 12.6% | 0.0% | 21.9% | 22.9% | 2.7% | 32.4% | 18.5% | 0.0% | 24.8% | 14.9% | 20.6% | 11.7% | -225.3% | -1.5% | -452.1% | -501.5% | -238.7% | -157.2% | -40.5% |
| EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | $-18.57M | $-1.42M | $-209.16M | $-218.04M | $-47.90M | $-51.57M | $-33.60M |
| EBITDA margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -201.1% | -2.2% | -1668.9% | -1656.3% | -220.3% | -168.4% | -36.4% |
| EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | $-20.80M | $-3.84M | $-216.51M | $-225.58M | $-55.69M | $-57.50M | $-37.38M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $69390.00 | $59567.00 | $42229.00 | $242000.00 | $119662.00 | $203000.00 | $241000.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $467.68M | $492.35M | — | $749.33M | $717.81M | $46.57M | $1.54B | $852.55M | — | $1.13B | $664.01M | $1.05B | $104.38M | $-20.14M | $-1.94M | $-174.01M | $-190.45M | $-62.72M | $-46.30M | $-58.32M |
| Net income growth (YoY) | — | +5.3% | -100.0% | — | -4.2% | -93.5% | +3200.3% | -44.5% | -100.0% | — | -41.5% | +58.9% | -90.1% | -119.3% | +90.4% | -8871.0% | -9.5% | +67.1% | +26.2% | -26.0% |
| Profit margin | 12.1% | 11.8% | 0.0% | 17.9% | 17.3% | 1.2% | 28.8% | 14.4% | 0.0% | 20.4% | 11.9% | 16.3% | 1.9% | -218.2% | -3.0% | -1388.4% | -1446.8% | -288.5% | -151.2% | -63.1% |